Evidence-based recommendations on cochlear implants for children and adults with severe to profound deafness.

Last reviewed: 7 March 2019

This guidance has been updated after a review of the criteria for defining severe to profound deafness and for assessing adequate benefit from acoustic hearing aids set out in recommendation 1.5. See section 4.4 of the guidance for further details. No other sections of the guidance have been updated, so these are the same as in the original guidance.

This guidance updates and replaces NICE technology appraisal guidance on cochlear implants for children and adults with severe to profound deafness (TA166).

View this resource on nice.org.uk

British Association of Paediatricians in Audiology is registered in England and Wales under company number 07445618 and Charity number 1142712
Log in | Powered by White Fuse